These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Sermion treatment of middle-aged and elderly patients with initial atherosclerotic encephalopathy].
    Author: Man'kovskiĭ NB, Mints AIa, Bachinskaia NIu, Kochubeĭ NV.
    Journal: Vrach Delo; 1989 Apr; (4):60-3. PubMed ID: 2756691.
    Abstract:
    The authors report results of a clinico-physiological study of the efficacy of a vasoactive agent sermion in patients with initial atherosclerotic encephalopathy indicating a positive effect of course treatment with this agent on the main clinical manifestations of the disease, pulse blood filling, bioelectric activity of the brain, psychomotor rate, mental working capacity, mnemonic function. Considering the established age-related differences in the efficacy of the agent, it is expedient to recommend sermion for long-term employment in the elderly. One should be cautious in instituting the drug in persons suffering of raised intraocular pressure.
    [Abstract] [Full Text] [Related] [New Search]